H.R. 6166: Lowering Drug Costs for American Families Act

H.R. 6166 is a federal bill in the 119th Congress. This legislation expands the number of drugs subject to Medicare price negotiation from 20 to 50 and allows private health insurance plans to voluntarily participate in these negotiated prices. Starting in 2027, private health plans must cap annual… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.